We then analyzed the Kaplan-Meier plots and found that higher KLB level (top 25%) was associated with longer overall survival (OS; n = 1145) and progression-free survival (PFS; n = 596) vs. lower KLB level (bottom 25%) in NSCLC (Figure. The gene discussed is KLB; the disease is non-small cell lung carcinoma.